γ-Aminobutyric Acid (A) Receptor Agonists Accelerate Cutaneous Barrier Recovery and Prevent Epidermal Hyperplasia Induced by Barrier Disruption  by Denda, Mitsuhiro et al.
ORIGINAL ARTICLE
See related Commentary on page 986
c-Aminobutyric Acid (A) Receptor Agonists Accelerate
Cutaneous Barrier Recovery and Prevent Epidermal
Hyperplasia Induced by Barrier Disruption
Mitsuhiro Denda, Kaori Inoue, Shinji Inomata, and Sumiko Denda
Shiseido Research Center, Fukuura, Kanazawa-ku,Yokohama, Japan
c-Aminobutyric acid, is an amino acid transmitter,
which mediates rapid inhibition in the central nervous
system. c-Aminobutyric acid (A) receptor is a ligand-
gated chloride ion channel playing an important part
in polarizing the cell membrane and reducing neuronal
excitability in the neuron. In this study, we demon-
strated the e¡ects of c-aminobutyric acid (A) receptor
agonists on the cutaneous barrier repair process after
the barrier disruption of hairless mice. Topical applica-
tion of c-aminobutyric acid and c-aminobutyric acid
(A) receptor-speci¢c agonists, musimol and isoguva-
cine, after barrier disruption accelerated the barrier re-
covery. The c-aminobutyric acid (B)-speci¢c agonist,
baclofen, did not a¡ect the barrier recovery rate. The
e¡ect of c-aminobutyric acid on the barrier recovery
was blocked by the c-aminobutyric acid (A)-receptor
antagonist, bicuculline methobromide, but c-aminobu-
tyric acid (B) receptor antagonist, saclofen, did not
a¡ect the e¡ect of c-aminobutyric acid.Topical applica-
tion of c-aminobutyric acid also prevented epidermal
hyperplasia, which was induced by the barrier insults
under low environmental humidity and bicuculline
methobromide blocked the e¡ect of c-aminobutyric
acid on the epidermal hyperplasia. Immunoreactivity
against c-aminobutyric acid (A) polyclonal antibody
was observed in hairless mouse epidermis. The £uores-
cent probe of c-aminobutyric acid (A) receptor, TXR-
musimol showed the localization of c-aminobutyric
acid (A) receptor in the epidermis of the hairless mice.
Elevation of intracellular chloride ion was induced by c-
aminobutyric acid in cultured human keratinocytes
and it was blocked by bicuculline methobromide.These
results suggest that the c-aminobutyric acid (A)-like re-
ceptor is associated with skin barrier homeostasis and
regulation of the receptor clinically e¡ective for barrier
dysfunctional or epidermal hyperproliferative diseases.
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O
ne of the most important roles of the skin for ter-
restrial mammals is to generate a water-imperme-
able barrier against excess transcutaneous water
loss. A decline in barrier function often parallels
increased severity of clinical symptomatology
(Elias and Feingold, 2001).When the stratum corneum barrier is
damaged, a series of homeostatic processes in the barrier function
is immediately accelerated, and the barrier recovers to its original
level (Elias and Feingold, 2001). This process includes lipid synth-
esis, lipid processing, and the acceleration of exocytosis of lamel-
lar bodies that contains the intercellular lipids (Elias and Feingold,
2001). Ion dynamics in the epidermis plays an important part in
barrier homeostasis, especially on the exocytosis of the lipid con-
taining lamellar bodies (Lee et al, 1994; Menon et al 1994). Menon
et al (1994) demonstrated that the increase of intercellular calcium
concentration perturbed the lamellar body secretion. Mauro et al
(1998) and Denda et al (2000) demonstrated that a drastic
alteration of calcium gradation occurred immediately after the
barrier disruption. Thus, the regulation of calcium ion dynamics
after the barrier insult might control the skin barrier homeostasis.
In neurons, several ligand-gated ion channels, such as glutamate
receptor or purinergic receptor, play an important part in
regulating the calcium £ux into the cell and depolarization of
the cell membrane (Shepherd, 1994a). On the contrary, the g-ami-
nobutyric acid (GABA) (A) receptor induces chloride ion £ux
and inhibited the depolarization (Shepherd, 1994b). The existence
of the GABA(A) receptor in the epidermal keratinocyte has been
suggested previously (Stoebner et al, 1999). Thus, we hypothesized
that we could improve the skin barrier homeostasis by the
regulation of GABA(A) receptor. In this study, we demonstrated
the e¡ects of GABA receptor agonist and also the e¡ect of GABA
receptor antagonists on the skin barrier recovery after the
barrier disruption of hairless mice. Moreover, we showed
an e¡ect of topical application of GABA on epidermal hyper-
plasia induced by barrier disruption under low environmental
humidity.
MATERIALS ANDMETHODS
Materials All experiments were performed on 7^10 wk old male hairless
mice (HR-1, Hoshino, Japan). All procedures for measuring skin barrier
function, disrupting the barrier, and applying the sample were carried out
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under anesthesia. All experiments were approved by the Animal Research
Committee of the Shiseido Research Center in accordance with the
National Research Council Guide (National Research Council, 1996).
GABA, muscimol, and baclofen were purchased from Wako (Osaka,
Japan). Isoguvacine and Saclofen were purchased from Tocris (Bristol,
U.K.). Bicuculline methobromide was purchased from ICN Biomedicals
Inc. (Aurora, OH). 6-methoxy-N-ethylquinolium iodide (MEQ), was pur-
chased from Molecular Probes (Eugene, OR). Normal human keratinocytes
(neonatal skin) was purchased from BioWhittaker (Walkersville, MD).
Cutaneous barrier function Permeability barrier function was
evaluated by measurement of transepidermal water loss (TEWL) with an
electric water analyzer, as described previously (Denda et al, 1998). For
barrier recovery experiments, both sides of £ank skin were treated with
repeated tape stripping until the TEWL reached 7^10 mg per cm2 per
hour, as described previously (Denda et al, 1998). Immediately after barrier
disruption, 100 ml of an aqueous solution containing 1 mM of reagent or
water alone (control) was applied to the treated area.We did not apply the
same reagent on both £anks. The areas were covered with plastic
membranes for 15 min and then the membranes were removed. Two
points on one side of £ank were measured and four to eight mice were
used to evaluate the e¡ects of each treatment. We always disrupted the
barrier between 07.00 and 08.00 h and carried out the following
measurements of the barrier repair to avoid the deviation of the repair rate
due to the in£uence of the circadian rhythm (Denda and Tsuchiya, 2000).
TEWL was then measured over the same sites at 1, 3, and 6 h after barrier
disruption.The barrier recovery results are expressed as percent of recovery,
because of variations from day to day in the extent of barrier disruption. In
each animal, the percentage of recovery was calculated by the following
formula:
ðTEWL immediately after barrier disruption
TEWL at indicated time pointÞ=
ðTEWL immediately after barrier disruptionbaselineTEWLÞ100%:
Epidermal hyperplasia induced by barrier disruption under low
humidity Animals were kept separately in 7.2 liter cages in which the
relative humidity was maintained at less than 10% with dry air as
described previously (Denda et al, 1998). The temperature was the same in
all cases (22^251C), and fresh air was circulated 100 times per hour. Animals
were kept out of the direct stream of air. During the experiments, the
animal’s behavior was not restricted. The level of NH3 was always below
1 p.p.m. Animals were ¢rst kept in a dry condition for 48 h and then the
skin on both £ank sides was treated with acetone-soaked cotton balls, as
described previously (Denda et al, 1998). The procedure was terminated
when TEWL reached 2.5^3.5 mg per cm2 per hour. Immediately after the
barrier disruption, 100 ml of GABA aqueous solution (1 mM) or mixture of
bicuculline methobromide and GABA (both 1 mM) was applied on one
side of the treated area. Water was applied on the other side. Then the
animals were again kept in the dry condition for 48 h. After the
experiments, animals were killed with diethylether inhalation and skin
samples were taken from the treated area. One hour before the killing,
20 ml per g body weight bromodeoxyuridine (BrdU) 10 mM solution was
injected intraperitoneally. Untreated control mice were also treated with
BrdU at the same time. After ¢xation with 4% paraformaldehyde, full
thickness skin samples were embedded in para⁄n, sectioned (4 mm), and
processed for hematoxylin and eosin staining. On each section, ¢ve areas
were selected at random; the thickness of the epidermis was measured
with an optical micrometer, and the mean value was calculated. For the
assessment of DNA synthesis, the sections were immunostained with
anti-BrdU antibodies. On each section, ¢ve areas were selected at random
from one section; the number of immunostained cells per 1mm of
epidermis was counted and the mean value was calculated. Measurements
were carried out in an observer-blinded fashion.
Immunohistochemistry Polyclonal anti-serum and blocking peptide
of GABA(A) receptor were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA). It was goat polyclonal antibody raised against a
peptide mapping near the C-terminus of GABA(A) receptor g3 subunit
of mouse origin. The anti-serum was diluted 500 : 1 with blocking
solution, i.e., 3% bovine albumin phosphate-bu¡ered saline (PBS)
solution containing 10% heat-inactivated goat serum and 0.4% Triton X-
100. Fluorescence secondary antibody was purchased from Molecular
Probes, Inc. (Alexa Fluor 488, anti-goat IgG conjugate). The secondary
antibody was also diluted 500 : 1 with the blocking solution. The
blocking peptides were reconstituted with 200 mL of PBS solution. For
blocking the antibody/antigen binding, the blocking peptide was used at
the ¢nal concentration 10 mM as suggested by the manufacturer. A 5 mm
frozen skin section was ¢xed with 201C methanol for 10 min and
soaked in PBS solution. Then the section was blocked with blocking
solution for 1 h at room temperature. The section was covered with
diluted anti-serum solution and kept at 41C overnight. The section was
washed with PBS solution containing 0.05% Tween 20 for 15 min, three
times, and covered with the secondary £uorescent antibody solution for 1 h
at room temperature. Then the section was washed with PBS solution,
including 0.05% Tween 20 for 15 min, three times, and mounted with
Vectashied (Vectashield with DAPI,Vector Laboratories, Inc., Burlingame,
CA). The section was observed and photographs were taken within 6 h.
Localization of GABA(A) receptor by £uorescent speci¢c
agonist Localization of GABA(A) receptor was observed by using
rhodamine-conjugated muscimol by the method used in a previous report
(Wang et al, 2000). Brie£y, skin samples were embedded in OCT and
frozen without any ¢xation. Then the tissue was sectioned 5 mm thickness
and ¢xed with methanol at ^201C. The section was incubated with 100 nM
of musimol conjugated to tetramethyl-rhodamine (Mus-TMX-R,
Molecular Probes) in PBS bu¡er for 1 h. Then the section was rinsed with
ice-cold PBS three times and mounted with Vectashield (Vectashield with
DAPI; Vector Laboratories). The section was observed and photographs
were taken within 6 h.
Evaluation of intracellular chloride in cultured normal human
keratinocyte To increase cell-membrane permeability, we reduced
MEQ to 6-methoxy-N-ethyl-1,2-dihydroquinoline (dihydro-MEQ) as
described previously (Biwersi and Verkman, 1991). Brie£y, reduction was
performed by addition of sodium bromohydrate (12% aqueous solution)
to an MEQ aqueous solution (16 mM) under nitrogen for 30 min dihydro-
MEQ was extracted with diethyl ether and dried with anhydrous MgSO4.
Then the solvent was evaporated under nitrogen. The culture medium was
replaced with the bu¡ered saline solution containing 150 mM NaCl, 10 mM
glucose, 25 mM HEPES, 5 mM KCl, 1.2 mM NaH2PO4, 1.2 mM MgCl2, and
1.8 mM CaCl2, adjusted pH 7.4 by NaOH.Then, dihydro-MEQ was added
at the ¢nal concentration of 50 mM on the cells and incubated for 15 min at
room temperature (21^231C). After washing with the saline and the cells
were incubated for a further 30 min to allow oxidation of the loaded
dihydro-MEQ. The coverslip was mounted on a £uorescence microscope
(IX70, TS Olympus, Tokyo, Japan) equipped with a 75 W xenon lamp
and band-path ¢lters of 340 nm. Measurements were carried out at room
temperature. Imaging data, recorded by a highly-sensitive silicon intensi¢er
target camera (C4742, Hamamatsu Photonics, Hamamatsu, Japan) were
regulated by a £uorescence analyzing system (AQUA/RATI01,
Hamamatsu Photonics). Fluorescence intensity is inversely related to
intracellular chloride ion concentration because the £uorescence of MEQ
is quenched collisionally by chloride ion (Biwersi and Verkman, 1991).
Statistical analysis The results are expressed as the mean7SD.
Statistical di¡erences between two groups were determined by a two-
tailed Student’s t test. In the case of more than two groups, di¡erences
were determined by ANOVA test (Fisher’s protected least signi¢cant
di¡erence).
RESULTS
Figure 1 shows the e¡ects of topical application of GABA recep-
tor agonists on skin barrier recovery after tape stripping. Topical
application of GABA and GABA(A)-type receptor agonists, mus-
cimol and isoguvacine, accelerated barrier repair. On the other
hand, the GABA(B)-type receptor agonist, baclofen, did not af-
fect the barrier recovery rate. These tendencies were observed 1, 3,
and 6 h after the treatment.These results suggest that activation of
GABA(A) receptor speci¢cally accelerates skin barrier recovery.
The e¡ects of GABA receptor antagonists are shown in Fig 2.
The e¡ect of GABA on barrier recovery was blocked by
GABA(A)-type receptor antagonist, bicuculline methobromide,
but GABA(B)-type receptor antagonist, saclofen, did not block
the e¡ect of GABA application. Topical application of bicuculline
methobromide or saclofen alone did not a¡ect the barrier recov-
ery rate. These results strongly support the results of Fig 1. The
e¡ect of GABA on the epidermal barrier recovery was likely to
depend on the GABA(A)-type receptor in the keratinocyte.
Topical application of GABA prevented the epidermal hy-
perplasia induced by acetone treatment under low environ-
mental humidity and the e¡ect was blocked by bicuculline
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methobromide (Fig 3). The representative sections are shown in
Fig 3. Figure 3(A) shows the hyperproliferative epidermis trea-
ted with water after the acetone treatment under low humidity.
Dark spots show BrdU-positive cells. The increase was seen on
the epidermal basal layer (Fig 3A). Topical application of 1 mM
GABA prevented the epidermal hyperplasia (Fig 3B). The
e¡ect of GABAwas blocked by 1 mM bicuculline methobromide
(Fig 3C). Figure 3(D) shows the untreated control. The quanti-
¢ed results of the epidermal thickness are shown in Fig 3(E).
Figure 3(F) shows the number of BrdU-positive cells in the
Figure1. GABA and GABA(A)-type receptor agonists, muscimol and isoguvacine, accelerated barrier repair. On the other hand, the GA-
BA(B)-type receptor agonist, baclofen, did not a¡ect the barrier recovery rate. The same tendency was observed at 1, 3, and 6 h after the treatment.Vertical
axes show the recovery percentage of each measurement time point to the level to the original level. Error bars show SD of each average. F¼173.440,
po0.001,Two points were measured in one £ank skin and four to eight animals were used for each treatment.
Figure 2. The e¡ect of GABAwas blocked by the GABA(A)-type receptor antagonist, bicuculline methobromide, but GABA(B)-type re-
ceptor antagonist, saclofen, did not block the e¡ect of GABA application. Topical application of bicuculline methobromide or saclofen alone did
not a¡ect the barrier recovery rate. The same tendency was observed at 1, 3, and 6 h after the treatment.Vertical axes show the recovery percentage of each
measurement time point to the level to the original level. Error bars show SD of each average. F¼119.415, po0.001,Two points were measured in one £ank
skin and four to six animals were used for each treatment.
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epidermis of the animals.The results show the same tendencies of
Fig 3(F). These results suggest that activation of GABA(A)
receptor is also e¡ective to prevent epidermal hyperproliferative
response induced by barrier insults.
Immunoreactivity against GABA(A)-receptor polyclonal anti-
body was observed in the epidermis (Fig 4A, green color).
Merged image with Nomarski microscopic observation and
DAPI staining was shown in (Fig 4B, blue color shows DNA).
The immunoreactivity against the GABA antibody was blocked
by a blocking peptide (Fig 4C, merged image with DAPI and
Nomarski: Fig 4D). The £uorescent GABA(A) probe shows loca-
lization of the GABA(A) receptor in the nucleated layer of the
hairless mouse epidermis (Fig 5A, a⁄nity against the probe
shows red color, merged image with DAPI and Nomarski:
Fig 5B) and it was reduced by preincubation with 1 mM bicu-
culline methobromide (Fig 5C, Merged image with DAPI and
Nomarski: Fig 5D). These results suggest a protein that has a
structure similar to GABA(A) receptor in epidermal keratino-
cytes.
A signi¢cant decrease in MEQ £uorescence, i.e., elevation of
intracellular chloride ion, was induced by 10 mM GABA after a
5 min incubation in cultured human keratinocytes and the de-
crease was blocked by 10 mM bicuculline methobromide (Fig 6).
The vertical axis shows the ratio of the £uorescence after a
5 min incubation to those before the treatment (mean7SD:
blank, 0.89470.044; GABA, 0.81470.048; GABA and BMB,
0.90870.069). These results suggest that functionally a GA-
BA(A)-like chloride channel exists on epidermal keratinocytes.
DISCUSSION
This study suggested the association of a GABA(A)-like receptor
on the cutaneous barrier homeostasis. The existence of a GABA
receptor in the epidermal keratinocytes has been suggested pre-
viously (Stoebner et al, 1999). Stoebner et al (1999) demonstrated
the expression of benzodiazepine receptor, which is an important
subunit of GABA(A) receptor, in super¢cial layers of human
epidermis. They also suggested that the benzodiazepine recep-
tors are associated with keratinocyte di¡erentiation. Previous
reports also demonstrated the existence of other receptors,
which were originally found in nerve cells. Ndoye et al (1998)
Figure 3. Topical application of GABA prevented the epidermal hyperplasia induced by acetone treatment under low environmental humid-
ity. (A^D) Dark spots show BrdU-positive cells. (A) Shows the hyperproliferative epidermis treated with water after the acetone treatment under the low
humidity. Topical application of 1 mM GABA prevented the epidermal hyperplasia (B). The e¡ect of GABAwas blocked by bicucullin methobromide (C).
The increase was seen on the epidermal basal layer (A). (D) Shows the untreated control. Bars¼ 20 mm.The quanti¢ed results of the epidermal thickness are
shown in (E). The topical application of GABA signi¢cantly reduced the epidermal thickness and it was blocked by bicucullin methobromide. The number
of BrdU-positive cells in the epidermis of each treatment (F) shows the same tendency as in (E). Error bars show SD of each average.
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demonstrated that each muscarinic acetylcholine receptor subtype
is localized di¡erently in the human epidermis. Genever et al
(1999) reported a glutamate-mediated signaling pathway in
keratinocytes.We recently demonstrated an immunoreactivity of
VR1, which was reported as a pain-related receptor, on epidermal
keratinocytes of human skin (Denda et al, 2001). Ectoderm-
derived keratinocytes and neurons show similar expression of
those receptors. The role and function of these receptors in the
epidermis should be investigated.
Previous studies suggest that an increase of intercellular cal-
cium in the keratinocyte perturbs the exocytosis of lamellar
bodies and delays skin barrier repair (Lee et al, 1994; Menon et al,
1994); however, the mechanistic study of the relationship between
lamellar body secretion and intracellular calcium ion in the kera-
tinocyte has not been clari¢ed. Phase transition and fusion of in-
tracellular granular membrane and cell membrane is a crucial
stage of the exocytosis and ions, such as calcium or magnesium
in£uence the exocytosis of the lamellar bodies (Denda et al, 2000;
Denda and Kumazawa, 2002). In healthy epidermis, a high
concentration of calcium is observed in the uppermost epidermis
and this gradation disappears immediately after barrier disruption
by tape stripping or treatment with organic solvent (Mauro et al,
1998; Denda et al, 2000). This drastic alteration of calcium grada-
tion might be a crucial signal for the barrier repair process.
Figure 4. Immunoreactivity against GABA(A) receptor polyclonal antibody was observed in the hairless mouse epidermis (A, green color).
Merged image with Nomarski microscopic observation and DAPI staining (blue color) is shown in (B). The immunoreactivity against the GABA antibody
was blocked by a blocking peptide: (C) merged image with DAPI, and (D) Nomarski. Bars¼ 20 mm.
Figure 5. The £uorescent GABA(A) probe shows localization of the GABA(A) receptor in the nucleated layer of the hairless mouse epider-
mis: (A) red color, merged image with DAPI, and (B) Nomarski microscopic observation. It was reduced by preincubation with bicucullin
methobromide: (C) merged image with DAPI, and (D) Nomarski. Bars¼ 20 mm.
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Zhang et al (2001) demonstrated that depolarization of cell mem-
brane causes an outward movement. An increase of intracellular
calcium ion might induce depolarization of the keratinocyte cell
membrane as in a neuron, perturb inward movement of cell
membrane, the exocytosis of lamellar body, and delay the barrier
repair. Previous studies demonstrated that adenosine triphosphate
(ATP) was secreted from epithelial cells by mechanistic or osmo-
tic stress and the secreted ATP induced an increase of the intracel-
lular calcium ion (Homolya et al, 2000; Schwiebert et al, 2001).We
observed an approximately 100% increase of ATP secretion from
skin in organ culture immediately after barrier disruption (data
not shown). Pillai and Bikle (1992) demonstrated the increase of
intracellular calcium ion in keratinocytes byATP. In neurons, the
GABA(A) receptor that forms a Cl^ channel plays a part of inhi-
biting of depolarization induced by cation £ux through other re-
ceptors, such as P2X, N-methyl-D-aspartate receptor (Shepherd,
1994b). Several reports suggest the existence of the Cl^ ion chan-
nel on the keratinocyte or other epithelial cells (Galietta et al, 1991;
Mauro et al, 1993). Potentially, the GABA(A)-like receptor we
present here might also inhibit depolarization of the keratinocyte
cell membrane. Like the nerve-system,‘‘inhibition’’ by the ligand-
gated chloride channel might be important for epidermal home-
ostasis. Barrier disruption might induce depolarization of the
keratinocyte cell membrane by autocrine signaling with ATP or
other transmitter. Re-polarization of the cell membrane by Cl^
£ux through GABA(A)-like receptor might block the outward
movement of the cell membrane and accelerate the fusion of the
lamellar body and cell membrane. It might consequently acceler-
ate exocytosis of lamellar bodies and cutaneous barrier repair pro-
cess. Electrophysiologic study should be studied also for better
understanding of the keratinocyte system.
Topical application of GABA not only accelerated barrier
repair but also reduced the epidermal hyperproliferative response
induced by acetone treatment under low environmental humid-
ity. The e¡ect on epidermal hyperplasia was blocked by bicucul-
line methobromide. The mechanism of GABA in the epidermal
hyperplasia has not been clari¢ed. GABA(A) receptor in kerati-
nocytes likely relates to epidermal proliferative response. Previous
studies suggest a correlation between an acceleration of skin bar-
rier recovery and improvement of the epidermal hyperplasia
(Denda et al, 1997, 1998; Ashida et al, 2001). The improvement of
the epidermal hyperplasia by the topical application of GABA
might be partially the result of acceleration of the barrier recov-
ery. On the other hand, increase of intracellular calcium ion is
related to keratinocyte proliferation, di¡erentiation, or in£amma-
tory responses (Yuspa et al, 1988). Chloride ion £ux into keratino-
cyte through GABA(A) receptor might also directly regulate the
metabolism of keratinocyte. Barrier disruption induces epidermal
DNA synthesis (Proksch et al, 1991) or cytokine generation
(Wood et al, 1992). E¡ects of GABA(A) agonist on keratinocyte
proliferation, di¡erentiation, or in£ammatory response such as
cytokine secretion should be investigated.
This study strongly suggests the existence of GABA(A) recep-
tor in the keratinocytes. In the brain, GABA(A) receptor is com-
posed of ¢ve di¡erent subtypes with di¡erent speci¢c types of
properties in di¡erent regions (Shepherd, 1994b). Localization of
each subunit of GABA(A)-like protein in the epidermis should
be investigated for further understanding of the role of the recep-
tor in the epidermal homeostasis.
In conclusion, topical application of GABA(A) receptor ago-
nists accelerated skin barrier recovery of hairless mice after its da-
mage and it was blocked by the GABA(A) receptor antagonist.
Topical application of GABA improved epidermal hyperplasia
under low environmental humidity and it was also blocked by
the GABA(A)-receptor antagonist. Immunoreactivity against
GABA(A) receptor polyclonal antibody and a⁄nity against £uor-
escent GABA(A) agonist was observed in the epidermis of hair-
less mice. Moreover, an increase of intracellular chloride ion in
cultured keratinocytes was induced by GABA and it was blocked
by the GABA(A)-receptor antagonist. These results suggest that
the GABA(A) receptor-like protein on the keratinocyte plays an
important part on skin barrier homeostasis.
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